Page 11 - Harvard Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Harvard Bioscience (NASDAQ:HBIO – Get Free Report) and Revvity (NYSE:RVTY – Get Free Report) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Profitability This table compares Harvard Bioscience and […]

Archon Capital Management LLC grew its stake in Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) by 4.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,361,769 shares of the medical instruments supplier’s stock after purchasing an additional 56,244 shares during the […]

Key Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is sensitive to their...

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 386,700 shares, an increase of 10.9% from the April 30th total of 348,800 shares. Currently, 1.0% of the company’s shares are short sold. Based […]

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 386,700 shares, an increase of 10.9% from the April 30th total of 348,800 shares. Approximately 1.0% of the shares of the company are sold short. Based on […]